CRP and atherosclerosis: Comparatively higher levels of anti-CRP antibodies in SA patients and healthy controls further support a potential immunoregulatory role for these antibodies in vascular inflammation, underscoring the importance of CRP–autoantibody interactions in the progression of atherosclerosis and cardiovascular risk [56].